+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cirrhosis Drug"

Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Hepatic Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatic Cirrhosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Global Liver Cirrhosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Liver Cirrhosis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Primary biliary cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary biliary cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Liver Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Liver Cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
From
From
Primary Biliary Cirrhosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Primary Biliary Cirrhosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Liver Cirrhosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Liver Cirrhosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Decompensated Cirrhosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Decompensated Cirrhosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
US Liver Cirrhosis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Liver Cirrhosis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
From
Loading Indicator

Cirrhosis is a serious liver disorder caused by long-term damage to the liver. It is characterized by scarring of the liver tissue, which can lead to liver failure. Treatment for cirrhosis typically involves medications to reduce inflammation, improve liver function, and reduce the risk of complications. Drugs used to treat cirrhosis include diuretics, antibiotics, antivirals, and immunosuppressants. The cirrhosis drug market is a subset of the larger liver and kidney disorders drugs market. It is composed of drugs used to treat cirrhosis and its associated complications. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Some companies in the cirrhosis drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more